Reporting J1444 under ESRD PPS
- By Renee Dustman
- In Coding
- May 2, 2019
- Comments Off on Reporting J1444 under ESRD PPS
In the quarterly update to the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS), a new HCPCS Level II code is being added for anemia management with an effective date of July 1, 2019.
J1444 Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron
This code is subject to Medicare Part B consolidated billing and, therefore, ESRD facilities will not receive separate payment for J1444 with or without modifier AY Item or service furnished to an ESRD patient that is not for the treatment of ESRD.
As will all drugs and biologicals that are furnished to ESRD patients via dialysate solution, append modifier JE Administered via dialysate to J1444 on bill type 72x.
MLN Matters MM11215
Managing Editor at AAPC
Renee Dustman, BS, AAPC MACRA Proficient, is managing editor - content & editorial at AAPC. She holds a Bachelor of Science degree in Media Communications - Journalism. Renee has more than 20 years experience in journalistic reporting, print production, graphic design, and content management. Follow her on Twitter @dustman_aapc.
Latest posts by Renee Dustman (see all)
- CMS Waives Part B Cost Sharing for More Services - February 24, 2021
- AAPC Social Hour: Becoming a Licensed Educator - February 12, 2021
- AAPC’s 2020 Salary Survey: Results Are In! - February 1, 2021
